AstraZeneca Criticizes HHS For Bid To Skirt Drug Price Suit
By Kaitlin Gebby · December 4, 2023, 7:48 PM EST
AstraZeneca has chided the federal government for seeking a quick win against the drugmaker's challenge to the Medicare drug price negotiation program in a recent brief, arguing that the Centers for...
To view the full article, register now.